14 May 2009

Partnership unites UCB with consumer product innovator OXO®

Read More
14 May 2009

UCB's CIMZIA® (certolizumab pegol) approved by the U.S. FDA for adult patients suffering from moderate to severe rheumatoid arthritis

Read More
8 May 2009

UCB seeking to acquire remaining Schwarz Pharma shares

Read More
30 Apr 2009

Statement of the CEO of UCB at the AGM: UCB executing on its strategy

Read More
30 Apr 2009

UCB focuses on new product launches

Read More
28 Apr 2009

UCB announces first results from Phase III brivaracetam studies in epilepsy

Read More
3 Mar 2009

UCB: Full Year 2008 Financial Results

Read More
20 Feb 2009

UCB announces top-line outcomes for proof-of-concept studies

Read More
20 Feb 2009

UCB to divest Equasym®

Read More
19 Feb 2009

UCB plans new biologics pilot plant in Braine-l'Alleud, Belgium

Read More
Subscribe to